A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
BicycleTx Limited
Nanobiotix
Incyte Corporation
Astellas Pharma Inc
Tempest Therapeutics
Nektar Therapeutics
Calithera Biosciences, Inc
Incyte Corporation